Search - tctmd.com

Displaying 41 - 60 of 63

Sort: Relevancy | Date

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

L.A. McKeown

September 11, 2017

Presentation VIVA 2017

ILLUMENATE European Randomized Trial: 2-Year Results

Presenter: Marianne Brodmann

September 11, 2017

Presentation VIVA 2017

Radiation Safety: How to Protect Yourself and the Patient

Presenter: Konstantinos Katsanos

September 11, 2017

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

L.A. McKeown

September 22, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Conference News VIVA 2016

IVUS Improves Management of Iliofemoral Venous Stenting

L.A. McKeown

September 20, 2016

Conference VIVA 2025

VIVA 2025

Las Vegas, NV

November 02, 2025

November 05, 2025

Conference VIVA 2024

VIVA 2024

Las Vegas, Nevada

November 03, 2024

November 06, 2024

Conference VIVA 2023

VIVA 2023

Las Vegas, Nevada

October 30, 2023

November 02, 2023

Conference VIVA 2022

VIVA 2022

October 31, 2022

November 03, 2022

Conference VIVA 2021

VIVA 2021

Las Vegas, NV

October 05, 2021

October 07, 2021

Conference VIVA 2020

VIVA 2020

November 06, 2020

November 14, 2020

Conference VIVA 2019

VIVA 2019

Las Vegas, NV

November 04, 2019

November 07, 2019

Conference VIVA 2018

VIVA 2018

Las Vegas, NV

November 05, 2018

November 08, 2018

Advertisement

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

EVAR Outcomes Equivalent Between Men and Women, Registries Show

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

ILLUMENATE European Randomized Trial: 2-Year Results

Radiation Safety: How to Protect Yourself and the Patient

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

IVUS Improves Management of Iliofemoral Venous Stenting

VIVA 2025

VIVA 2024

VIVA 2023

VIVA 2022

VIVA 2021

VIVA 2020

VIVA 2019

VIVA 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content